TWI799959B - CD40 agonist antibodies and methods of use - Google Patents

CD40 agonist antibodies and methods of use Download PDF

Info

Publication number
TWI799959B
TWI799959B TW110130787A TW110130787A TWI799959B TW I799959 B TWI799959 B TW I799959B TW 110130787 A TW110130787 A TW 110130787A TW 110130787 A TW110130787 A TW 110130787A TW I799959 B TWI799959 B TW I799959B
Authority
TW
Taiwan
Prior art keywords
methods
agonist antibodies
agonist
antibodies
Prior art date
Application number
TW110130787A
Other languages
Chinese (zh)
Other versions
TW202222833A (en
Inventor
楊寶田
李進
鄭勇
Original Assignee
大陸商上海藥明生物技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商上海藥明生物技術有限公司 filed Critical 大陸商上海藥明生物技術有限公司
Publication of TW202222833A publication Critical patent/TW202222833A/en
Application granted granted Critical
Publication of TWI799959B publication Critical patent/TWI799959B/en

Links

TW110130787A 2020-08-21 2021-08-20 CD40 agonist antibodies and methods of use TWI799959B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
WOPCT/CN2020/110536 2020-08-21
CN2020110536 2020-08-21
CN202110904019.9 2021-08-06
CN202110904019 2021-08-06

Publications (2)

Publication Number Publication Date
TW202222833A TW202222833A (en) 2022-06-16
TWI799959B true TWI799959B (en) 2023-04-21

Family

ID=83062602

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110130787A TWI799959B (en) 2020-08-21 2021-08-20 CD40 agonist antibodies and methods of use

Country Status (1)

Country Link
TW (1) TWI799959B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554414A (en) * 2015-09-18 2017-04-05 科济生物医药（上海）有限公司 The immune effector cell of anti-CD19 human antibodies and targeting CD19
WO2018115859A1 (en) * 2016-12-20 2018-06-28 Kymab Limited Multispecific antibody with combination therapy for immuno-oncology
CN108373505A (en) * 2018-04-20 2018-08-07 北京智仁美博生物科技有限公司 Anti- IL-4R antibody and application thereof
CN109071665A (en) * 2016-04-18 2018-12-21 塞德斯医疗公司 In conjunction with the agonistic antibody and application thereof of people CD40

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554414A (en) * 2015-09-18 2017-04-05 科济生物医药（上海）有限公司 The immune effector cell of anti-CD19 human antibodies and targeting CD19
CN109071665A (en) * 2016-04-18 2018-12-21 塞德斯医疗公司 In conjunction with the agonistic antibody and application thereof of people CD40
WO2018115859A1 (en) * 2016-12-20 2018-06-28 Kymab Limited Multispecific antibody with combination therapy for immuno-oncology
CN108373505A (en) * 2018-04-20 2018-08-07 北京智仁美博生物科技有限公司 Anti- IL-4R antibody and application thereof

Also Published As

Publication number Publication date
TW202222833A (en) 2022-06-16

Similar Documents

Publication Publication Date Title
GB202019709D0 (en) Anti-Coronavirus antibodies and methods of use
DK3966207T3 (en) PHENYLAMINOPYRIMIDINAMIDE AUTOPHAGY INHIBITORS AND METHODS OF USING THEREOF
DK3966206T3 (en) HETEROARYLAMINOPYRIMIDINAMIDE AUTOPHAGY INHIBITORS AND METHODS OF USING THEREOF
DK3618928T3 (en) Anti-Sortilin antibodies and methods of use thereof
SG11202007739XA (en) Arginase inhibitors and methods of use thereof
EP3810617A4 (en) Ectonucleotidase inhibitors and methods of use thereof
KR20220035452A (en) Immunomodulatory antibodies and methods of use thereof
EP3765006A4 (en) Arginase inhibitors and methods of use
IL287768A (en) Kcnt1 inhibitors and methods of use
IL287751A (en) Kcnt1 inhibitors and methods of use
IL284640A (en) Pcsk9 inhibitors and methods of use thereof
IL287973A (en) Acss2 inhibitors and methods of use thereof
IL284661A (en) Pcsk9 inhibitors and methods of use thereof
EP3810615A4 (en) Arginase inhibitors and methods of use
EP3897622A4 (en) Arginase inhibitors and methods of use
KR20220035450A (en) IRAK inhibitors and methods for their preparation and use
EP3846808A4 (en) Papd5 inhibitors and methods of use thereof
IL280924A (en) Arginase inhibitors and methods of use thereof
SG11202100555PA (en) Anti-siglec-5 antibodies and methods of use thereof
KR20220035322A (en) PI4-kinase inhibitors and methods of use thereof
TWI799959B (en) CD40 agonist antibodies and methods of use
IL308260A (en) Anti-tigit antibodies and methods of use thereof
IL285108A (en) Arginase inhibitors and methods of use thereof
GB201818477D0 (en) Tissue plasminogen activator antibodies and method of use thereof
IL309349A (en) Anti-il-9 antibodies and methods of use thereof